Table 1.
Round 1 (n = 13) | Round 2 (n = 13) | |
---|---|---|
Mean ± SD | Mean ± SD | |
Age at time of focus group | 63.31 ± 2.68 (49–81) | 66.15 ± 1.96(56–77) |
Months since diagnosis | 25.23 ± 31.88 (2–124) | 9.85 ± 8.51 (3–36) |
N (%) | N (%) | |
Educational levela | ||
Low | 0 (0%) | 0 (0%) |
Medium | 8 (61%) | 8 (61%) |
High | 4 (31%) | 3 (23%) |
Unknown | 1 (8%) | 2 (16%) |
Marital status | ||
Partnered | 12 (92%) | 11 (85%) |
Widowed/no partner | 1 (8%) | 2 (15%) |
Diagnosis | ||
NSCLC | 12 (85%) | 10 (77%) |
SCLC | 1 (8%) | 3 (23%) |
Treatment | ||
Curative therapy (surgery or stereotactic radiotherapy) | 4 (31%) | 4 (31%) |
Curative intent (chemoradiation therapy) | 3 (23%) | 6 (46%) |
Palliative chemotherapy | 6 (46%) | 3 (23%) |
aLow = < 10 years of education, medium = 10–14 years of education, high = > 14 years of education
NSLC non-small-cell lung cancer, SCLC small-cell lung cancer